BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6347782)

  • 1. Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes.
    Pagano G; Tagliaferro V; Carta Q; Caselle MT; Bozzo C; Vitelli F; Trovati M; Cocuzza E
    Diabetologia; 1983 May; 24(5):351-4. PubMed ID: 6347782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport.
    Herman R; Kravos NA; Jensterle M; Janež A; Dolžan V
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and Molecular Mechanisms of Metformin Action.
    LaMoia TE; Shulman GI
    Endocr Rev; 2021 Jan; 42(1):77-96. PubMed ID: 32897388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipotoxicity and
    Ye R; Onodera T; Scherer PE
    J Endocr Soc; 2019 Mar; 3(3):617-631. PubMed ID: 30834357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
    Priya G; Kalra S
    Diabetes Ther; 2018 Feb; 9(1):349-361. PubMed ID: 29139080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate Levels with Chronic Metformin Use: A Narrative Review.
    Huang W; Castelino RL; Peterson GM
    Clin Drug Investig; 2017 Nov; 37(11):991-1007. PubMed ID: 28836132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk in double diabetes mellitus--when two worlds collide.
    Cleland SJ
    Nat Rev Endocrinol; 2012 Apr; 8(8):476-85. PubMed ID: 22488644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?
    Culina S; Boitard C; Mallone R
    Clin Dev Immunol; 2011; 2011():286248. PubMed ID: 21647401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of metformin in type 1 diabetes: a systematic review of efficacy.
    Vella S; Buetow L; Royle P; Livingstone S; Colhoun HM; Petrie JR
    Diabetologia; 2010 May; 53(5):809-20. PubMed ID: 20057994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents.
    Abdelghaffar S; Attia AM
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006691. PubMed ID: 19160294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
    Lund SS; Tarnow L; Astrup AS; Hovind P; Jacobsen PK; Alibegovic AC; Parving I; Pietraszek L; Frandsen M; Rossing P; Parving HH; Vaag AA
    PLoS One; 2008; 3(10):e3363. PubMed ID: 18852875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: new understandings, new uses.
    Hundal RS; Inzucchi SE
    Drugs; 2003; 63(18):1879-94. PubMed ID: 12930161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk-benefit assessment of metformin in type 2 diabetes mellitus.
    Howlett HC; Bailey CJ
    Drug Saf; 1999 Jun; 20(6):489-503. PubMed ID: 10392666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antidiabetic drug use in the elderly.
    Bressler R; Johnson DG
    Drugs Aging; 1996 Dec; 9(6):418-37. PubMed ID: 8972242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.
    Ilarde A; Tuck M
    Drugs Aging; 1994 Jun; 4(6):470-91. PubMed ID: 8075474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin requirement for the antihyperglycaemic effect of metformin.
    Bailey CJ; Mynett KJ
    Br J Pharmacol; 1994 Mar; 111(3):793-6. PubMed ID: 7912625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.
    Donnelly R; Morris AD
    Br J Clin Pharmacol; 1994 Apr; 37(4):311-20. PubMed ID: 7912538
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral hypoglycaemic agents. An update.
    Asmal AC; Marble A
    Drugs; 1984 Jul; 28(1):62-78. PubMed ID: 6378583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin receptor concept and its relation to the treatment of diabetes.
    Ward GM
    Drugs; 1987 Feb; 33(2):156-70. PubMed ID: 3552593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.